Sign in

CIK 0001855485 · <br>Emerging growth company

Calidi Biotherapeutics, Inc.

Sign in to watch
Tickers
CLDI CLDWW
Exchange
NYSE, OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
862967193
Phone
858-794-9600
Business address
4475 EXECUTIVE DRIVE, SUITE 200, SAN DIEGO, CA, 92121
Former names
Calidi Biotherapeutics, Inc., First Light Acquisition Group, Inc.

Securities

  • CLDI Calidi Biotherapeutics, Inc. Common Stock NYSE
  • CLDWW Common stock OTC
  1. 8-K Event Regulation FD disclosure
  2. NT 10-Q Other NT 10-Q
  3. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  4. 425 Deal Prospectus/Communication re Business Combination
  5. EFFECT Other Notice of Effectiveness
  6. 424B3 Offering Prospectus
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. S-4/A Deal Registration Statement - Business Combination
  9. S-4/A Deal Registration Statement - Business Combination
  10. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  11. S-4/A Deal Registration Statement - Business Combination
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. 425 Deal Prospectus/Communication re Business Combination
  14. UPLOAD Other SEC-generated Letter
  15. S-4/A Deal Registration Statement - Business Combination
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. SC 13D/A Stake Beneficial Ownership Report
  18. 425 Deal Prospectus/Communication re Business Combination
  19. 8-K Event Material agreement · Regulation FD disclosure
  20. 8-K Event Other events

Page 16 of 21 · 406 filings